Alumis Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ALMS Nasdaq 2836 www.alumis.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Alumis Inc.

Alumis Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares - Jan 9th, 2026 2:05 pm
Assessing Alumis (ALMS) Valuation After Positive Phase 3 Psoriasis Data And Strong Share Price Momentum - Jan 8th, 2026 1:13 am
Alumis Announces Pricing of Upsized Public Offering of Common Stock - Jan 7th, 2026 8:52 pm
Psoriasis Market to Exhibit Growth at a CAGR of 1.7% During the Forecast Period (2025-2034), Owing to Continuous Innovation in Biologic Therapies and Approval of Oral Small Molecules | DelveInsight - Jan 7th, 2026 3:31 pm
ALMS Surges as Envudeucitinib Meets Goals in Plaque Psoriasis Studies - Jan 7th, 2026 9:52 am
Should You Chase the Rally in Alumis Stock Today? - Jan 7th, 2026 9:35 am
Stock Market Today, Jan. 6: Alumis Shares Surge on Positive Phase 3 Psoriasis Data for Envudeucitinib - Jan 6th, 2026 3:32 pm
Alumis Stock Catapults More Than 95% As Biotech Takes On J&J, Protagonist In Psoriasis - Jan 6th, 2026 2:29 pm
Alumis Announces Proposed Public Offering of Common Stock - Jan 6th, 2026 2:12 pm
Wall Street Consolidates, Driving Muted Premarket Action for US Equity Futures - Jan 6th, 2026 7:16 am
Alumis’ Envudeucitinib Delivers Leading Skin Clearance Among Next-Generation Oral Plaque Psoriasis Therapies in Phase 3 Program - Jan 6th, 2026 5:00 am
Alumis soars as TYK2 drug hits mark in psoriasis trials - Jan 6th, 2026 4:50 am
Alumis to Host Conference Call and Webcast to Report Phase 3 ONWARD Topline Data for Envudeucitinib in Moderate-to-Severe Plaque Psoriasis - Jan 5th, 2026 3:00 pm
Alumis Reports Third Quarter 2025 Financial Results and Highlights Recent Progress - Nov 13th, 2025 2:15 pm
Alumis to Participate in Upcoming November Investor Conferences - Nov 4th, 2025 6:00 am
Positive Signs As Multiple Insiders Buy Alumis Stock - Sep 26th, 2025 4:22 am
Alumis to Participate in Upcoming September Investor Conferences - Aug 29th, 2025 5:00 am
Alumis Inc. Beat Analyst Profit Forecasts, And Analysts Have New Estimates - Aug 16th, 2025 6:25 am
Alumis Reports Second Quarter 2025 Financial Results and Provides Corporate Update - Aug 13th, 2025 2:05 pm
While institutions invested in Alumis Inc. (NASDAQ:ALMS) benefited from last week's 4.1% gain, individual investors stood to gain the most - Aug 10th, 2025 8:28 am